Calidi Biotherapeutics

If you happened to miss Calidi Biotherapeutics' recent webinar with Chief Financial Officer, Andrew Jackson, and Chief Scientific Officer, Antonio F. Santidrian. Ph.D., here's your chance to learn more about Calidi's RTNova virotherapy platform. #calidi #RTNova #virotherapy

Join Us for an Exciting Webinar: Latest advancements in Calidi's RTNova platform and clinical progress ???Date: Monday, March 17 ???Time: 4:15 PM ET Hope to see you there! Use the following link to register now: https://lnkd.in/eufnMNRA Antonio F. Santidrian. Ph.D. Andrew Jackson

Calidi Biotherapeutics is thrilled to announce the presentation of new data of our systemic virotherapy RTNova Platform at the American Association for Cancer Research (AACR) Annual Meeting in April 2025. The data presented will focus on the development of Calidi's proprietary RTNova systemic platform, showcasing its potential to overcome current barriers in metastatic cancer treatment by enabling targeted systemic delivery to multiple tumor sites without rapid elimination by the body’s immune system. Read more here: https://lnkd.in/gPg8p4TK #calidi #virotherapy #AACR #RTNova

?? Calidi Biotherapeutics recognizes Wendy Pizarro, Esq., our Chief Legal Officer and Chief Diversity Officer, as a speaker today, October 21, 2024, at the San Diego Precision in Clinical Trials Summit in San Diego, CA. Sherri Monroe She will be speaking on Diversity, Equity and Inclusion Strategies in Clinical Trials and Patient Recruitment. Please reach out to her if you will be attending! #calidi #clinicaltrials #PCTSUMMIT #DEI #endcancer $CLDI

Calidi Biotherapeutics' Chief Business Officer, Steve Thesing, recently interviewed with Dave Gentry, CEO of RedChip Companies, discussing Calidi's cancer therapies and their place in the future of oncology. Click below for the full interview: #calidi #oncology #virotherapy #endcancer $CLDI

Congratulations to?Calidi Biotherapeutics' Chief Legal Officer and Chief Diversity Officer,?Wendy Pizarro, Esq., for being awarded as a "2024 DEIA Visionary" by the L.A. Times B2B Publishing for her advocacy on health equity in innovative clinical trials. ? Read more here: https://lnkd.in/gd5v6aVf #DEI #healthequity #deia #indigenouspeoplesday

Calidi Biotherapeutics is thrilled to announce FDA Clearance of the Northwestern University IND Application for Calidi's NeuroNova (CLD-101) Clinical Trial in Newly Diagnosed High-Grade Glioma. Congratulations to the NWU and Calidi teams! Read more below: #calidi #IND #clinicaltrial #virotherapy #neuronova $CLDI #glioblastoma #highgradeglioma #braincancer

Missed Our Virtual Presentation? Watch the Replay Now! Yesterday, we at Calidi Biotherapeutics hosted an exciting virtual presentation diving deep into the groundbreaking science and innovative technology we’re developing to combat cancer. If you missed it, don’t worry! You can catch the full replay and discover how our pioneering approaches are transforming the future of cancer treatment. Watch the Replay Here:?https://lnkd.in/gnGR7Fmf Join us on this journey towards a world free from the threat of cancer. Your support and curiosity drive our mission forward! #CalidiBio #CancerResearch #Biotechnology #Innovation #Science #Healthcare

Join Us for an Exciting Webinar: Calidi’s Groundbreaking Cancer Treatment ???Date: September 11th ? ???Time: 4:15 PM ET Discover the future of cancer treatment with Calidi! Our developmental drug targets and destroys cancer cells throughout the body while leaving healthy cells unharmed. Don’t miss this opportunity to learn more about this revolutionary therapy. ???Register now: #calidi #virotherapy #endcancer $CLDI

Calidi Biotherapeutics?was recently featured in an article by?Fred Grier?with the?San Diego Business Journal, highlighting the launch of our new subsidiary, Nova Cell. Read more below! #calidi #novacell #stemcells #biotech #sandiego $CLDI